SMTL ID : 9hb8.1

Crystal structure of human tryptophan hydroxylase 2 in complex with inhibitor KM-06-098

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

homo-tetramer

Ligands

4 x FE: FE (III) ION(Non-covalent)

FE.1: 4 residues within 4Å: Chain A: H.200, H.205, E.245 Ligands: UVU.2 5 PLIP interactions: 4 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:H.200, A:H.205, A:E.245, A:E.245, H2O.1 FE.3: 4 residues within 4Å: Chain B: H.200, H.205, E.245 Ligands: UVU.4 5 PLIP interactions: 4 interactions with chain B, 1 Ligand-Water interactions Metal complexes: B:H.200, B:H.205, B:E.245, B:E.245, H2O.1 FE.5: 4 residues within 4Å: Chain C: H.200, H.205, E.245 Ligands: UVU.6 5 PLIP interactions: 4 interactions with chain C, 1 Ligand-Water interactions Metal complexes: C:H.200, C:H.205, C:E.245, C:E.245, H2O.1 FE.7: 4 residues within 4Å: Chain D: H.200, H.205, E.245 Ligands: UVU.8 5 PLIP interactions: 4 interactions with chain D, 1 Ligand-Water interactions Metal complexes: D:H.200, D:H.205, D:E.245, D:E.245, H2O.1

4 x UVU: 3-ethyl-8-[(2-methylimidazo[2,1-b][1,3]thiazol-6-yl)methyl]-7-[[4-(1-methylpyrazol-3-yl)phenyl]methyl]purine-2,6-dione(Non-covalent)

UVU.2: 16 residues within 4Å: Chain A: Y.53, G.54, G.162, Y.163, L.164, P.166, F.169, Y.183, P.194, E.195, P.196, H.200, A.237, Y.240, E.245 Ligands: FE.1 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:Y.163, A:Y.163, A:P.196, A:A.237, A:Y.240 Hydrogen bonds: A:Y.163, A:L.164, A:L.164, A:Y.183 pi-Stacking: A:F.169, A:F.169 UVU.4: 15 residues within 4Å: Chain B: M.52, Y.53, G.162, Y.163, L.164, P.166, F.169, Y.183, E.195, P.196, H.200, A.237, Y.240, E.245 Ligands: FE.3 11 PLIP interactions: 11 interactions with chain B Hydrophobic interactions: B:Y.163, B:Y.163, B:F.169, B:P.196, B:A.237, B:Y.240 Hydrogen bonds: B:Y.163, B:L.164, B:L.164 pi-Stacking: B:F.169, B:F.169 UVU.6: 16 residues within 4Å: Chain C: Y.53, G.54, G.162, Y.163, L.164, P.166, F.169, Y.183, P.194, E.195, P.196, H.200, A.237, Y.240, E.245 Ligands: FE.5 11 PLIP interactions: 11 interactions with chain C Hydrophobic interactions: C:Y.163, C:Y.163, C:P.196, C:A.237, C:Y.240 Hydrogen bonds: C:Y.163, C:L.164, C:L.164, C:Y.183 pi-Stacking: C:F.169, C:F.169 UVU.8: 15 residues within 4Å: Chain D: M.52, Y.53, G.162, Y.163, L.164, P.166, F.169, Y.183, E.195, P.196, H.200, A.237, Y.240, E.245 Ligands: FE.7 11 PLIP interactions: 11 interactions with chain D Hydrophobic interactions: D:Y.163, D:Y.163, D:F.169, D:P.196, D:A.237, D:Y.240 Hydrogen bonds: D:Y.163, D:L.164, D:L.164 pi-Stacking: D:F.169, D:F.169

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wesolowski, R. et al., Selectivity and Safety Characterization of a Xanthine-Imidazothiazole Lead Structure: a Novel Tryptophan Hydroxylase Inhibitor of Peripheral Serotonin Synthesis. Acs Pharmacol Transl Sci (2025)

Release Date

2025-07-16

Peptides

Tryptophan 5-hydroxylase 2: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

Tryptophan 5-hydroxylase 2

Related Entries With Identical Sequence